These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 13745248)

  • 1. [Comparative research on the dosage frequency in sulfonamide therapy of experimental infections].
    SACKMANN W; NEIPP L
    Pathol Microbiol (Basel); 1960; 23():568-74. PubMed ID: 13745248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and clinical research on the sulfonamide "Madribon"].
    GLANZMANN H
    Munch Med Wochenschr; 1960 Dec; 102():2467-70. PubMed ID: 13705916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative analysis of the diuretic activity of the recent synthetic sulfonamide compounds].
    GOBBATO F; TURCHETTO P
    Minerva Nefrol; 1960; 7():91-3. PubMed ID: 13706147
    [No Abstract]   [Full Text] [Related]  

  • 4. A mechanistical model for the uptake of sulfonamides by bacteria.
    Zarfl C; Matthies M; Klasmeier J
    Chemosphere; 2008 Jan; 70(5):753-60. PubMed ID: 17765286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl sulfonamide anti-proliferatives. Part 2: activity of heterocyclic sulfonamide derivatives.
    Mader MM; Shih C; Considine E; Dios AD; Grossman CS; Hipskind PA; Lin HS; Lobb KL; Lopez B; Lopez JE; Cabrejas LM; Richett ME; White WT; Cheung YY; Huang Z; Reilly JE; Dinn SR
    Bioorg Med Chem Lett; 2005 Feb; 15(3):617-20. PubMed ID: 15664824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of amino acid sulfonamides as transition-state analogue inhibitors of arginase.
    Cama E; Shin H; Christianson DW
    J Am Chem Soc; 2003 Oct; 125(43):13052-7. PubMed ID: 14570477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimisation of a potent and selective tertiary sulfonamide oxytocin antagonist.
    Barton NP; Bellenie BR; Doran AT; Emmons AJ; Heer JP; Salvagno CM
    Bioorg Med Chem Lett; 2009 Jan; 19(2):528-32. PubMed ID: 19081251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
    Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the saluretic effect of a sulfonamide derivative].
    FRISCHAUF H; WENGER R
    Wien Med Wochenschr; 1961 Mar; 111():164-6. PubMed ID: 13702125
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pharmacodynamic action of the new sulfonamide 2-(p-aminobenzenesulfonamido)-4,5-dimethyloxazole].
    DEININGER R; GUTBROD H
    Arzneimittelforschung; 1960 Aug; 10():612-9. PubMed ID: 13721299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the pharmacological study of sulfadimethoxine, an antibacterial sulfonamide with prolonged action].
    SAVEL J
    Therapie; 1960; 15():952-66. PubMed ID: 13746886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on a new sulfonamide combination with prolonged action].
    TUBARO E; PIZZOGLIO L; RAFFALDONI E
    Boll Chim Farm; 1958 Jan; 97(1):9-15. PubMed ID: 13510333
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the new sulfonamide 2-sulfanilamide-4,5-dimethyloxazole (sulfuno) with special reference to excretion through the bile].
    GERNER G
    Munch Med Wochenschr; 1960 Aug; 102():1611-6. PubMed ID: 13704681
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-experimental studies on the long-acting sulfonamide Durenat].
    DIPPON M; TRAUT H
    Med Welt; 1963 Jul; 29():1488-93. PubMed ID: 14028015
    [No Abstract]   [Full Text] [Related]  

  • 15. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
    Huang H; Pan X; Tan N; Zeng G; Ji C
    Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulfonamide-research on human subjects in Nazi concentration camps: a critical re-evaluation of the epistemological and ethical dimension].
    Roelcke V
    Medizinhist J; 2009; 44(1):42-60. PubMed ID: 19496525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
    Chen L; Petrelli R; Olesiak M; Wilson DJ; Labello NP; Pankiewicz KW
    Bioorg Med Chem; 2008 Aug; 16(15):7462-9. PubMed ID: 18583139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylsulfonamides: a study of the relationship between activity and conformational preferences for a series of factor Xa inhibitors.
    Senger S; Convery MA; Chan C; Watson NS
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5731-5. PubMed ID: 16982192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pANM 1, a plasmid coding for sulfonamide resistance in Neisseria meningitidis.
    Facinelli B; Biavasco F; Carini D
    J Chemother; 1989 Jul; 1(4 Suppl):305-6. PubMed ID: 16312413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.